Table 3.
Response assessment | Evaluation criteria |
---|---|
CR | All target lesions have disappeared during the course of treatment and the pathological lymph nodes are reduced to <10 mm |
PR | Decreases of at least 30% from base line have been noted in the sum of LD of target lesions |
PD | There has been an increase of at least 20% in the sum of the LD of targeted lesions, and it is emphasized that the absolute value of the increased sum of LD is 5 mm, or new lesions appeared |
SD | Between PD and PR |